Literature DB >> 23148994

Simple and rapid detection method for the mutations in SLC22A12 that cause hypouricemia by allele-specific real-time polymerase chain reaction.

Shota Takagi1, Risa Omae, Juliet O Makanga, Tetsuya Kawahara, Tetsuya Inazu.   

Abstract

BACKGROUND: Hypouricemia is a disorder that serum urate level is less than 2.0 mg/dl, and relatively common in the Japanese population, where the main genetic cause of hypouricemia is W258X and R90H mutations in human urate trasnsporter 1(SLC22A12). Small scale screening has relied on time-consuming traditional ways like polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Therefore, it is beneficial that we have an easy and rapid detection method for these mutations.
METHODS: In this report, we established a touchdown allele-specific real-time polymerase chain reaction (ASPCR) assay for detecting W258X and R90H mutations in SLC22A12, respectively.
RESULTS: Quantifiable discrimination was successfully achieved by ∆Ct value. Furthermore, we conducted W258X and R90H screening against 120 control genome sets, whereby frequency was 2.92% for W258X, and not detected for R90H, respectively.
CONCLUSIONS: The two mutations, W258X and R90H in SLC22A12 were successfully genotyped by an easy and rapid ASPCR assay.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148994     DOI: 10.1016/j.cca.2012.10.046

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction.

Authors:  Dana Gabrikova; Jarmila Bernasovska; Jitka Sokolova; Blanka Stiburkova
Journal:  Urolithiasis       Date:  2015-06-02       Impact factor: 3.436

Review 2.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

3.  Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.

Authors:  Zhaowei Zhou; Ke Wang; Juan Zhou; Can Wang; Xinde Li; Lingling Cui; Lin Han; Zhen Liu; Wei Ren; Xuefeng Wang; Keke Zhang; Zhiqiang Li; Dun Pan; Changgui Li; Yongyong Shi
Journal:  Mol Genet Genomic Med       Date:  2019-05-26       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.